Encouraging Results After Discontinuation of Cancer Immunotherapy Due to Immune AEs

MedPage Today) — Patients who discontinued cancer immunotherapy because of immune-related adverse events (irAEs) often had durable benefits despite not receiving the planned course of treatment, a retrospective study of patients with lung cancer…